Dr. Pravin Patil, Rheumatologist gives a comprehensive overview of Ankylosing spondylitis (AS) and how it is different from spondylosis and regular back pain, tips on managing this condition and the role of exercise.
Ankylosing spondylitis (AS) is a disease of young adults. Regrettably, ankylosing spondylitis has very little identity unto its own. Anything with “spondylitis” is considered to be linked with old age or simple ‘wear and tear’. Adding the prefix “ankylosing”…

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition